Sokolova V, Gruber R, Pammer L, Kocher F, Klieser E, Amann A
Mol Biol Rep. 2024; 52(1):87.
PMID: 39729162
PMC: 11680630.
DOI: 10.1007/s11033-024-10169-5.
Ke C, Wu H, Wang Y, Huang W, Lin C
Biomedicines. 2024; 12(4).
PMID: 38672200
PMC: 11047836.
DOI: 10.3390/biomedicines12040846.
Wang Z, Wang X, Shi Y, Wu S, Ding Y, Yao G
Front Med (Lausanne). 2024; 11:1330491.
PMID: 38566927
PMC: 10985158.
DOI: 10.3389/fmed.2024.1330491.
Fang K, Su C, Layos J, Lau N, Cheng K
Cancers (Basel). 2024; 16(5).
PMID: 38473403
PMC: 10930734.
DOI: 10.3390/cancers16051046.
Strippoli R, Niayesh-Mehr R, Adelipour M, Khosravi A, Cordani M, Zarrabi A
Cancers (Basel). 2024; 16(4).
PMID: 38398197
PMC: 10886827.
DOI: 10.3390/cancers16040807.
Cyclin Dependent Kinase Inhibitor 2A Genetic and Epigenetic Alterations Interfere with Several Immune Components and Predict Poor Clinical Outcome.
Soltan M, Alhanshani A, Shati A, Alqahtani Y, Alshaya D, Alharthi J
Biomedicines. 2023; 11(8).
PMID: 37626750
PMC: 10452213.
DOI: 10.3390/biomedicines11082254.
Fluoride-induced apoptosis in non-skeletal tissues of experimental animals: A systematic review and meta-analysis.
Angwa L, Nyadanu S, Kanyugo A, Adampah T, Pereira G
Heliyon. 2023; 9(8):e18646.
PMID: 37560699
PMC: 10407679.
DOI: 10.1016/j.heliyon.2023.e18646.
Transforming Diagnosis and Therapeutics Using Cancer Genomics.
Mehmood S, Aslam S, Dilshad E, Ismail H, Khan A
Cancer Treat Res. 2023; 185:15-47.
PMID: 37306902
DOI: 10.1007/978-3-031-27156-4_2.
The Interplay between T Cells and Cancer: The Basis of Immunotherapy.
Chen C, Liu X, Chang C, Wang H, Wang R
Genes (Basel). 2023; 14(5).
PMID: 37239368
PMC: 10218245.
DOI: 10.3390/genes14051008.
Cancer resistance via the downregulation of the tumor suppressors and expressions: therapeutic implications.
Moghaddam M, Vivarelli S, Falzone L, Libra M, Bonavida B
Explor Target Antitumor Ther. 2023; 4(2):170-207.
PMID: 37205308
PMC: 10185445.
DOI: 10.37349/etat.2023.00128.
Revisiting Cryptocyanine Dye, NK-4, as an Old and New Drug: Review and Future Perspectives.
Liu S, Matsuo T, Abe T
Int J Mol Sci. 2023; 24(5).
PMID: 36901839
PMC: 10002675.
DOI: 10.3390/ijms24054411.
Murine Models of Chronic Viral Infections and Associated Cancers.
Avdoshina D, Kondrashova A, Belikova M, Bayurova E
Mol Biol. 2022; 56(5):649-667.
PMID: 36217336
PMC: 9534466.
DOI: 10.1134/S0026893322050028.
The ECRG4 cleavage product augurin binds the endotoxin receptor and influences the innate immune response during otitis media.
Kurabi A, Hur D, Pak K, Gibson M, Webster N, Baird A
Front Genet. 2022; 13:932555.
PMID: 36092940
PMC: 9461705.
DOI: 10.3389/fgene.2022.932555.
Uncovering Oncogenic Mechanisms of Tumor Suppressor Genes in Breast Cancer Multi-Omics Data.
Cho S
Int J Mol Sci. 2022; 23(17).
PMID: 36077026
PMC: 9455665.
DOI: 10.3390/ijms23179624.
FAM107A Inactivation Associated with Promoter Methylation Affects Prostate Cancer Progression through the FAK/PI3K/AKT Pathway.
Ke S, Liu Z, Wang Q, Zhai G, Shao H, Yu X
Cancers (Basel). 2022; 14(16).
PMID: 36010909
PMC: 9405870.
DOI: 10.3390/cancers14163915.
Comparative Pathobiology of Canine and Human Prostate Cancer: State of the Art and Future Directions.
Nascente E, Amorim R, Fonseca-Alves C, de Moura V
Cancers (Basel). 2022; 14(11).
PMID: 35681707
PMC: 9179314.
DOI: 10.3390/cancers14112727.
LncRNA MEG3 inhibits the development of nasopharyngeal carcinoma by sponging miR-543 targeting KLF4.
Ning J, Zhang L, Guo H, Zhou S, Sun X, Bao W
Transl Cancer Res. 2022; 9(2):958-971.
PMID: 35117441
PMC: 8798555.
DOI: 10.21037/tcr.2019.12.41.
Identification and External Validation of a Transcription Factor-Related Prognostic Signature in Pediatric Neuroblastoma.
Wang R, Wang Q
J Oncol. 2022; 2021:1370451.
PMID: 34992653
PMC: 8727167.
DOI: 10.1155/2021/1370451.
Bona Fide Tumor Suppressor Genes Hypermethylated in Melanoma: A Narrative Review.
Guvenc C, Neckebroeck F, Antoranz A, Garmyn M, van den Oord J, Maria Bosisio F
Int J Mol Sci. 2021; 22(19).
PMID: 34639015
PMC: 8508892.
DOI: 10.3390/ijms221910674.
Identification of a Novel Transcription Factor Prognostic Index for Breast Cancer.
Liu J, Liu Z, Zhou Y, Zeng M, Pan S, Liu H
Front Oncol. 2021; 11:666505.
PMID: 34249704
PMC: 8264286.
DOI: 10.3389/fonc.2021.666505.